A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea

被引:3
|
作者
Seo, Ji-Hye [1 ]
Kim, Ock-Joo [1 ]
Yoo, Sang-Ho [2 ]
Choi, Eun Kyung [3 ]
Park, Ji-Eun [4 ]
机构
[1] Seoul Natl Univ, Dept Hist Med & Med Humanities, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Hanyang Univ, Dept Med Human & Eth, Coll Med, Seoul, South Korea
[3] Korea Natl Inst Bioeth Policy, Seoul, South Korea
[4] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea
关键词
phase I clinical trials; healthy volunteers; informed consent; research ethics;
D O I
10.1177/15562646211034275
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The phase I trial is the first step in administering a drug to humans, but it has no therapeutic purpose. Under the absence of therapeutic purpose, healthy volunteers demonstrated different motivations, unlike the actual patients participating in trials. There were many reported motivations, such as financial motivation, contributing to the health science, accessing ancillary health care benefits, scientific interest or interest in the goals of the study, meeting people, and general curiosity. The aim of this study was to identify the motivation and characteristics of healthy volunteers participating in phase I trials in the Republic of Korea. We gave surveys to 121 healthy volunteers to study their demographic characteristics and the reasons of participation. We identified whether the decision to participate in the research was influenced by demographic factors and whether the perception and attitudes toward the research were influenced by the characteristics of the healthy volunteers. After completion of the first survey, 12 healthy volunteers who had participated in a phase I clinical trial were selected to answer the second interview. According to our survey, most healthy volunteers were unmarried men and economically dependent. Most of them participated in the study because of financial reward. The most important factor to measure financial reward was the research period. Also, 43% of the volunteers were university students, 42% answered "university graduation" and 55% were residing in family-owned houses. Many healthy volunteers were found to be living in family homes and to have a student status or lack of economic independence. Results of the survey showed that 64% of respondents indicated having more than one clinical trial participation. In-depth interviews showed that healthy volunteers had diverse motivation to participate in research and that healthy volunteer perceive the clinical trial positively. The main motivation for healthy volunteers' participation in research was "financial reward." Healthy volunteers also considered research schedules, processes, and safety, and had a positive perception of clinical trials, but they thought that the public has a negative perception.
引用
收藏
页码:193 / 212
页数:20
相关论文
共 50 条
  • [1] Characteristics, Motivations, and Preferences of Healthy Volunteers in Phase I Clinical Trials in Sweden
    Rein-Hedin, Erik
    Schultzberg, Marten
    Sjoberg, Folke
    Huss, Fredrik
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2025,
  • [2] Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time
    Kalbaugh, Corey A.
    Kalbaugh, Julianne M.
    McManus, Lisa
    Fisher, Jill A.
    PLOS ONE, 2021, 16 (09):
  • [3] Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials
    Fisher, Jill A.
    McManus, Lisa
    Wood, Megan M.
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Monahan, Torin
    Walker, Rebecca L.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2018, 13 (05) : 494 - 510
  • [4] CHARACTERISTICS OF VOLUNTEERS WHO PARTICIPATE IN PHASE-I AND PHASE-II DRUG DEVELOPMENT STUDIES
    DEVRIES, B
    HUGHES, GS
    FRANCOM, SF
    CLINICAL RESEARCH, 1988, 36 (03): : A362 - A362
  • [5] Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study
    Fisher, Jill A.
    McManus, Lisa
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Wood, Megan M.
    Monahan, Torin
    Walker, Rebecca L.
    PLOS MEDICINE, 2018, 15 (11):
  • [6] The secret realm of phase I trials in healthy volunteers
    Kimmelman, Jonathan
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [7] PERSONALITY OF HEALTHY-VOLUNTEERS PARTICIPATING IN PHASE-I CLINICAL-TRIALS
    CAMI, J
    LLORENTE, M
    FARRE, M
    BADENAS, JM
    PERSONALITY AND INDIVIDUAL DIFFERENCES, 1989, 10 (11) : 1199 - 1200
  • [8] Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration
    Gupta, Pooja
    Gupta, Veena
    Gupta, Yogendra K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (04) : 540 - U128
  • [9] Interpersonal Values of Healthy Subjects Who Volunteer for Phase I Clinical Trials
    Luis Almeida
    Manuel Vaz-da-Silva
    Rui Coelho
    António Albino-Teixeira
    Patrício Soares-da-Silva
    Pharmaceutical Medicine, 2009, 23 (5-6) : 299 - 303
  • [10] A retrospective study: screening failure analysis of 1,058 healthy volunteers in phase I clinical trials
    Li, Hongmin
    Liu, Ying
    He, Yuanyuan
    Chen, Ran
    Guo, Peng
    Wang, Na
    Liu, Boxin
    Cheng, Xinxin
    Tang, Liyuan
    Dai, Xinya
    Sun, Xiaoyang
    Li, Weihong
    Wang, Ying
    Zhang, Lijuan
    Wang, Yanrong
    Bai, Xibo
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (07) : 2464 - 2477